Clinical evaluation of targeted arterial infusion of verapamil in the interventional chemotherapy of primary hepatocellular carcinoma.

Clinical evaluation of targeted arterial infusion of verapamil in the interventional chemotherapy of primary hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q34588085
Giant Lysosomes as a Chemotherapy Resistance Mechanism in Hepatocellular Carcinoma CellsClinical evaluation of targeted arterial perfusion of verapamil and chemotherapeutic drugs in interventional therapy of advanced lung cancer.Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma.Treatment of malignant ascites with a combination of chemotherapy drugs and intraperitoneal perfusion of verapamil.Upregulation of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Mediates the Reversal Effect of Verapamil on Chemo-Resistance to Adriamycin of Hepatocellular Carcinoma.Post-TACE combination therapy of heparin and octreotide results in decreased tumor metastasis in extrahepatic tumorigenesis.Studies on assessment methods of malignant ascites residue and changes of verapamil concentration in intraperitoneal perfusion chemotherapy.
P2860

Clinical evaluation of targeted arterial infusion of verapamil in the interventional chemotherapy of primary hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q34588085
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical evaluation of targete ...... mary hepatocellular carcinoma.
@ast
Clinical evaluation of targete ...... mary hepatocellular carcinoma.
@en
Clinical evaluation of targete ...... mary hepatocellular carcinoma.
@nl
type
label
Clinical evaluation of targete ...... mary hepatocellular carcinoma.
@ast
Clinical evaluation of targete ...... mary hepatocellular carcinoma.
@en
Clinical evaluation of targete ...... mary hepatocellular carcinoma.
@nl
prefLabel
Clinical evaluation of targete ...... mary hepatocellular carcinoma.
@ast
Clinical evaluation of targete ...... mary hepatocellular carcinoma.
@en
Clinical evaluation of targete ...... mary hepatocellular carcinoma.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Clinical evaluation of targete ...... mary hepatocellular carcinoma.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932